Diabetes-associated macrovascular complications: Cell-based therapy a new tool?

Endocrine

Volumn 44, Issue 3, 2013, Pages 557-575

  Gili, Maddalena ^a   Orsello, Alberto ^a   Gallo, Sara ^a   Brizzi, Maria Felice ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Cardiovascular diseases; Cell based therapy; Diabetes

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ADIPOSE DERIVED STEM CELL; ANGIOGENESIS; BRAIN ISCHEMIA; DIABETIC ANGIOPATHY; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; FIBRINOLYTIC THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; TREATMENT OUTCOME;

CARDIOVASCULAR DISEASES; CELL- AND TISSUE-BASED THERAPY; DIABETES COMPLICATIONS; HUMANS;

EID: 84890790055     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-9936-8     Document Type: Review

References (207)

1. F. Ismail-Beigi, Clinical practice. Glycemic management of type 2 diabetes mellitus. N. Engl. J. Med. 366, 1319-1327 (2012)
2. N. Chaturvedi, The burden of diabetes and its complications: trends and implications for intervention. Diabetes Res. Clin. Pract. 76, S3-S12 (2007)
3. P. Patel, A. Macerollo, Diabetes mellitus: diagnosis and screening. Am. Fam. Physician 81, 863-870 (2010)
4. S. Keymel, Y. Heinen, J. Balzer, T. Rassaf, M. Kelm, T. Lauer, C. Heiss, Characterization of macro-and microvascular function and structure in patients with type 2 diabetes mellitus. Am. J. Cardiovasc. Dis. 1, 68-75 (2011)
5. S.M. Marshall, A. Flyvbjerg, Prevention and early detection of vascular complications of diabetes. BMJ 333, 475-480 (2006)
6. A.R. Pries, B. Reglin, T.W. Secomb, Remodeling of blood vessels: responses of diameter and wall thickness to hemodynamic and metabolic stimuli. Hypertension 46, 725-731 (2005)
7. A.M. Heagerty, C. Aalkjaer, S.J. Bund, N. Korsgaard, M.J. Mulvany, Small artery structure in hypertension. Dual processes of remodeling and growth. Hypertension 21, 391-397 (1993)
8. D.M. Nathan, P.A. Cleary, J.Y. Backlund, S.M. Genuth, J.M. Lachin, T.J. Orchard, P. Raskin, B. Zinman, Diabetes, Control and complication Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group.: intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N. Engl. J. Med. 353, 2643-2653 (2005)
9. A. Martin, M.R. Komada, D.C. Sane, Abnormal angiogenesis in diabetes mellitus. Med. Res. Rev. 23, 117-145 (2003)
10. S. Patan, Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling. J. Neurooncol. 50, 1-15 (2000)
11. T. Asahara, T. Murohara, A. Sullivan, M. Silver, R. van der Zee, T. Li, B. Witzenbichler, G. Schatteman, J.M. Isner, Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967 (1997)
12. W. Risau, Mechanisms of angiogenesis. Nature 386, 671-674 (1997)
13. J. Folkman, Angiogenesis. Annu. Rev. Med. 57, 1-18 (2006)
14. S. Banai, M.T. Jaklitsch, M. Shou, D.F. Lazarous, M. Scheinowitz, S. Biro, S.E. Epstein, E.F. Unger, Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89, 2183-2189 (1994)
15. S. Takeshita, L.P. Zheng, E. Brogi, M. Kearney, L.Q. Pu, S. Bunting, N. Ferrara, J.F. Symes, J.M. Isner, Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J. Clin. Invest. 93, 662-670 (1994)
16. E.F. Unger, S. Banai, M. Shou, D.F. Lazarous, M.T. Jaklitsch, M. Scheinowitz, R. Correa, C. Klingbeil, S.E. Epstein, Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am. J. Physiol. 266, 1588-1595 (1994)
17. D.F. Lazarous, M. Scheinowitz, M. Shou, E. Hodge, S. Rajanayagam, S. Hunsberger, W.G. Robison Jr, J.A. Stiber, R. Correa, S.E. Epstein, Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation 91, 145-153 (1995)
18. D.F. Lazarous, M. Shou, M. Scheinowitz, E. Hodge, V. Thirumurti, A.N. Kitsiou, J.A. Stiber, A.D. Lobo, S. Hunsberger, E. Guetta, S.E. Epstein, E.F. Unger, Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation 94, 1074-1082 (1996)
19. H.T. Yang, M.R. Deschenes, R.W. Ogilvie, R.L. Terjung, Basic fibroblast growth factor increases collateral blood flow in rats with femoral arterial ligation. Circ. Res. 79, 62-69 (1996)
20. J.J. Lopez, R.J. Laham, A. Stamler, J.D. Pearlman, S. Bunting, A. Kaplan, J.P. Carrozza, F.W. Sellke, M. Simons, VEGF administration in chronic myocardial ischemia in pigs. Cardiovasc. Res. 40, 272-281 (1998)
21. R. Morishita, S. Nakamura, S. Hayashi, Y. Taniyama, A. Moriguchi, T. Nagano, M. Taiji, H. Noguchi, S. Takeshita, K. Matsumoto, T. Nakamura, J. Higaki, T. Ogihara, Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension 33, 1379-1384 (1999)
22. D.J. Collinson, R. Donnelly, Therapeutic angiogenesis in peripheral arterial disease: can biotechnology produce an effective collateral circulation? Eur. J. Vasc. Endovasc. Surg. 28, 9-23 (2004)
23. M. Heil, I. Eitenmuller, T. Schmitz-Rixen, W. Schaper, Arteriogenesis versus angiogenesis: similarities and differences. J. Cell Mol. Med. 10, 45-55 (2006)
24. H. Gerhardt, M. Golding, M. Fruttiger, C. Ruhrberg, A. Lundkvist, A. Abramsson, M. Jeltsch, C. Mitchell, K. Alitalo, D. Shima, C. Betsholtz, VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J. Cell Biol. 161, 1163-1177 (2003)
25. S. Patel-Hett, P.A. D'Amore, Signal transduction in vasculogenesis and developmental angiogenesis. Int. J. Dev. Biol. 55, 353-363 (2011)
26. M. Heil, W. Schaper, Cellular mechanisms of arteriogenesis. Exs, 181-191 (2005)
27. I. Eitenmuller, O. Volger, A. Kluge, K. Troidl, M. Barancik, W.J. Cai, M. Heil, F. Pipp, S. Fischer, A.J. Horrevoets, T. Schmitz-Rixen, W. Schaper, The range of adaptation by collateral vessels after femoral artery occlusion. Circ. Res. 99, 656-662 (2006)
28. J. Waltenberger, J. Lange, A. Kranz, Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: a potential predictor for the individual capacity to develop collaterals. Circulation 102, 185-190 (2000)
29. V. Tchaikovski, S. Olieslagers, F.D. Bohmer, J. Waltenberger, Diabetes mellitus activates signal transduction pathways resulting in vascular endothelial growth factor resistance of human monocytes. Circulation 120, 150-159 (2009)
30. E. Tateishi-Yuyama, H. Matsubara, T. Murohara, U. Ikeda, S. Shintani, H. Masaki, K. Amano, Y. Kishimoto, K. Yoshimoto, H. Akashi, K. Shimada, T. Iwasaka, T. Imaizumi, Therapeutic angiogenesis using cell transplantation study, I.: therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360, 427-435 (2002)
31. O. Honmou, K. Houkin, T. Matsunaga, Y. Niitsu, S. Ishiai, R. Onodera, S. G. Waxman, J. D. Kocsis, Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain:134, 1790-1807 (2011)
32. M. Gnecchi, P. Danieli, E. Cervio, Mesenchymal stem cell therapy for heart disease. Vasc. Pharmacol. 57, 48-55 (2012)
33. G.O. Ouma, R.A. Jonas, M.H. Usman, E.R. Mohler 3rd, Targets and delivery methods for therapeutic angiogenesis in peripheral artery disease. Vasc. Med. 17, 174-192 (2012)
34. C. Kalka, H. Masuda, T. Takahashi, W. M. Kalka-Moll, M. Silver, M. Kearney, T. Li, J. M. Isner, T. Asahara, Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. U S A 97, 3422-3427 (2000)
35. O. Jeon, S.W. Kang, H.W. Lim, D. Choi, D.I. Kim, S.H. Lee, J.H. Chung, B.S. Kim, Synergistic effect of sustained delivery of basic fibroblast growth factor and bone marrow mononuclear cell transplantation on angiogenesis in mouse ischemic limbs. Biomaterials 27, 1617-1625 (2006)
36. A. Aicher, M. Rentsch, K. Sasaki, J.W. Ellwart, F. Fandrich, R. Siebert, J.P. Cooke, S. Dimmeler, C. Heeschen, Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ. Res. 100, 581-589 (2007)
37. M. Jiang, B. Wang, C. Wang, B. He, H. Fan, T.B. Guo, Q. Shao, L. Gao, Y. Liu, Angiogenesis by transplantation of HIF-1 alpha modified EPCs into ischemic limbs. J. Cell. Biochem. 103, 321-334 (2008)
38. M. Gnecchi, Z. Zhang, A. Ni, V.J. Dzau, Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res. 103, 1204-1219 (2008)
39. Y. Jeong, D.J. Mangelsdorf, Nuclear receptor regulation of stemness and stem cell differentiation. Exp. Mol. Med. 41, 525-537 (2009)
40. A. Keating, Mesenchymal stromal cells: new directions. Cell stem cell 10, 709-716 (2012)
41. A. Blum, W. Balkan, J.M. Hare, Advances in cell-based therapy for peripheral vascular disease. Atherosclerosis 223, 269-277 (2012)
42. P. Anversa, J. Kajstura, M. Rota, A. Leri, Regenerating new heart with stem cells. J. Clin. Invest. 123, 62-70 (2013)
43. S. Matoba, T. Tatsumi, T. Murohara, T. Imaizumi, Y. Katsuda, M. Ito, Y. Saito, S. Uemura, H. Suzuki, S. Fukumoto, Y. Yamamoto, R. Onodera, S. Teramukai, M. Fukushima, H. Matsubara, TACT follow-up study investigators. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (therapeutic angiogenesis by cell transplantation [tact] trial) in patients with chronic limb ischemia. Am. Heart J. 156, 1010-1018 (2008)
44. J.S. Lee, J.M. Hong, G.J. Moon, P.H. Lee, Y.H. Ahn, O.Y. Bang, A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem cells 28, 1099-1106 (2010)
45. G. Astori, F. Bambi, G. Soldati, D. Surder, T. Moccetti, Autologous bone marrow mononucleated cell preparation for the clinical treatment of acute myocardial infarction and peripheral arterial disease. Cytotherapy 13, 1031-1035 (2011)
46. S.I. Savitz, V. Misra, M. Kasam, H. Juneja, C.S. Cox Jr, S. Alderman, I. Aisiku, S. Kar, A. Gee, J.C. Grotta, Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Ann. Neurol. 70, 59-69 (2011)
47. D.M. Clifford, S.A. Fisher, S.J. Brunskill, C. Doree, A. Mathur, S. Watt, E. Martin-Rendon, Stem cell treatment for acute myocardial infarction (Cochrane Database Syst., Rev, 2012)
48. H. Zimmet, P. Porapakkham, P. Porapakkham, Y. Sata, S.J. Haas, S. Itescu, A. Forbes, H. Krum, Short- and long-term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials. Eur. J. Heart Fail. 14, 91-105 (2012)
49. C.K. Rebelatto, A.M. Aguiar, M.P. Moretao, A.C. Senegaglia, P. Hansen, F. Barchiki, J. Oliveira, J. Martins, C. Kuligovski, F. Mansur, A. Christofis, V.F. Amaral, P.S. Brofman, S. Goldenberg, L.S. Nakao, A. Correa, Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp Biol Med (Maywood) 233, 901-913 (2008)
50. G.C. Schatteman, M. Dunnwald, C. Jiao, Biology of bone marrow-derived endothelial cell precursors. Am. J. Physiol. Heart Circ. Physiol. 292, H1-H18 (2007)
51. D.P. Sieveking, M.K. Ng, Cell therapies for therapeutic angiogenesis: back to the bench. Vasc. med. 14, 153-166 (2009)
52. G.Q. Jia, M.M. Zhang, P. Yang, J.Q. Cheng, Y.R. Lu, X.T. Wu, Effects of the different culture and isolation methods on the growth, proliferation and biology characteristics of rat bone marrow mesenchymal stem cells. Sichuan Da Xue Xue Bao Yi Xue Ban. 40, 719-723 (2009)
53. N. Hibino, A. Nalbandian, L. Devine, R.S. Martinez, E. McGillicuddy, T. Yi, S. Karandish, G.A. Ortolano, T. Shin'oka, E. Snyder, C.K. Breuer, Comparison of human bone marrow mononuclear cell isolation methods for creating tissue-engineered vascular grafts: novel filter system versus traditional density centrifugation method. Tissue Eng. 17, 993-998 (2011)
54. M. Gnecchi, L.G. Melo, Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium. Methods Mol. Biol. 482, 281-294 (2009)
55. G. Condorelli, U. Borello, L. De Angelis, M. Latronico, D. Sirabella, M. Coletta, R. Galli, G. Balconi, A. Follenzi, G. Frati, M.G. De Cusella Angelis, L. Gioglio, S. Amuchastegui, L. Adorini, L. Naldini, A. Vescovi, E. Dejana, G. Cossu, Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration. Proc. Natl. Acad. Sci. U. S. A. 98, 10733-10738 (2001)
56. N.F. Grigoropoulos, A. Mathur, Stem cells in cardiac repair. Curr. Opin. Pharmacol. 6, 169-175 (2006)
57. T.J. Burdon, A. Paul, N. Noiseux, S. Prakash, D. Shum-Tim, Bone marrow stem cell derived paracrine factors for regenerative medicine: current perspectives and therapeutic potential. Bone Marrow Res. 2011, 207326 (2011)
58. M.C. Yoder, L.E. Mead, D. Prater, T.R. Krier, K.N. Mroueh, F. Li, R. Krasich, C.J. Temm, J.T. Prchal, D.A. Ingram, Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109, 1801-1809 (2007)
59. W. Wojakowski, U. Landmesser, R. Bachowski, T. Jadczyk, M. Tendera, Mobilization of stem and progenitor cells in cardiovascular diseases. Leukemia 26, 23-33 (2012)
60. M.C. Yoder, D.A. Ingram, Endothelial progenitor cell: ongoing controversy for defining these cells and their role in neoangiogenesis in the murine system. Curr. Opin. Hematol. 16, 269-273 (2009)
61. M. Mayr, D. Niederseer, J. Niebauer, From bench to bedside: what physicians need to know about endothelial progenitor cells. Am. J. Med. 124, 489-497 (2011)
62. S. Shintani, T. Murohara, H. Ikeda, T. Ueno, T. Honma, A. Katoh, K. Sasaki, T. Shimada, Y. Oike, T. Imaizumi, Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103, 2776-2779 (2001)
63. P. Huang, S. Li, M. Han, Z. Xiao, R. Yang, Z.C. Han, Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care 28, 2155-2160 (2005)
64. H. Ince, M. Petzsch, H.D. Kleine, H. Eckard, T. Rehders, D. Burska, S. Kische, M. Freund, C.A. Nienaber, Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and stem cell liberation in evolving acute myocardial infarction by granulocyte colony-stimulating factor (FIRSTLINE-AMI) trial. Circulation 112, I73-I80 (2005)
65. R.S. Ripa, E. Jorgensen, Y. Wang, J.J. Thune, J.C. Nilsson, L. Sondergaard, H.E. Johnsen, L. Kober, P. Grande, J. Kastrup, Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation 113, 1983-1992 (2006)
66. Y. Suarez, B.R. Shepherd, D.A. Rao, J.S. Pober, Alloimmunity to human endothelial cells derived from cord blood progenitors. J. Immunol. 179, 7488-7496 (2007)
67. E. M. Horwitz, P. L. Gordon, W. K. Koo, J. C. Marx, M. D. Neel, R. Y. McNall, L. Muul, T. Hofmann, Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc. Natl. Acad. Sci. U S A 99, 8932-8937 (2002)
68. H.M. Lazarus, S.E. Haynesworth, S.L. Gerson, N.S. Rosenthal, A.I. Caplan, Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant. 16, 557-564 (1995)
69. J. Cai, M.L. Weiss, M.S. Rao, In search of "stemness". Exp. Hematol. 32, 585-598 (2004)
70. N.J. Zvaifler, L. Marinova-Mutafchieva, G. Adams, C.J. Edwards, J. Moss, J.A. Burger, R.N. Maini, Mesenchymal precursor cells in the blood of normal individuals. Arthr. res. 2, 477-488 (2000)
71. J.G. Toma, M. Akhavan, K.J. Fernandes, F. Barnabe-Heider, A. Sadikot, D.R. Kaplan, F.D. Miller, Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat. Cell Biol. 3, 778-784 (2001)
72. U. Noth, A.M. Osyczka, R. Tuli, N.J. Hickok, K.G. Danielson, R.S. Tuan, Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J. Orthop. Res. 20, 1060-1069 (2002)
73. I. Rogers, R.F. Casper, Umbilical cord blood stem cells. Best. Pract. Res. Clin. Obstet. Gynaecol. 18, 893-908 (2004)
74. S. Kern, H. Eichler, J. Stoeve, H. Kluter, K. Bieback, Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem cells 24, 1294-1301 (2006)
75. A.H. Klopp, A. Gupta, E. Spaeth, M. Andreeff, F. Marini 3rd, Concise review: dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? Stem cells 29, 11-19 (2011)
76. Y. Jiang, B.N. Jahagirdar, R.L. Reinhardt, R.E. Schwartz, C.D. Keene, X.R. Ortiz-Gonzalez, M. Reyes, T. Lenvik, T. Lund, M. Blackstad, J. Du, S. Aldrich, A. Lisberg, W.C. Low, D.A. Largaespada, C.M. Verfaillie, Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41-49 (2002)
77. M. Dominici, K. Le Blanc, I. Mueller, I. Slaper-Cortenbach, F. Marini, D. Krause, R. Deans, A. Keating, D. Prockop, E. Horwitz, Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317 (2006)
78. H. Nakagami, R. Morishita, K. Maeda, Y. Kikuchi, T. Ogihara, Y. Kaneda, Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy. J. Atheroscler. Thromb. 13, 77-81 (2006)
79. G. Chamberlain, J. Fox, B. Ashton, J. Middleton, Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem cells 25, 2739-2749 (2007)
80. S. Tomita, R. K. Li, R. D. Weisel, D. A. Mickle, E. J. Kim, T. Sakai, Z. Q. Jia, Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100, II247-256 (1999)
81. M.F. Pittenger, B.J. Martin, Mesenchymal stem cells and their potential as cardiac therapeutics. Circ. Res. 95, 9-20 (2004)
82. D.G. Phinney, D.J. Prockop, Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem cells 25, 2896-2902 (2007)
83. B.A. Bunnell, M. Flaat, C. Gagliardi, B. Patel, C. Ripoll, Adipose-derived stem cells: isolation, expansion and differentiation. Methods 45, 115-120 (2008)
84. T. Murohara, Autologous adipose tissue as a new source of progenitor cells for therapeutic angiogenesis. J. Cardiol. 53, 155-163 (2009)
85. K. Kondo, S. Shintani, R. Shibata, H. Murakami, R. Murakami, M. Imaizumi, Y. Kitagawa, T. Murohara, Implantation of adipose-derived regenerative cells enhances ischemia-induced angiogenesis. Arterioscler. Thromb. Vasc. Biol. 29, 61-66 (2009)
86. J. Rehman, D. Traktuev, J. Li, S. Merfeld-Clauss, C.J. Temm-Grove, J.E. Bovenkerk, C.L. Pell, B.H. Johnstone, R.V. Considine, K.L. March, Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109, 1292-1298 (2004)
87. H. Nakagami, K. Maeda, R. Morishita, S. Iguchi, T. Nishikawa, Y. Takami, Y. Kikuchi, Y. Saito, K. Tamai, T. Ogihara, Y. Kaneda, Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler. Thromb. Vasc. Biol. 25, 2542-2547 (2005)
88. F. Mosna, L. Sensebe, M. Krampera, Human bone marrow and adipose tissue mesenchymal stem cells: a user's guide. Stem cells dev. 19, 1449-1470 (2010)
89. P.C. Baer, H. Geiger, Adipose-derived mesenchymal stromal/stem cells: tissue localization, characterization, and heterogeneity. Stem cells int. 2012, 812693 (2012)
90. N. Tremain, J. Korkko, D. Ibberson, G.C. Kopen, C. DiGirolamo, D.G. Phinney, MicroSAGE analysis of 2,353 expressed genes in a single cell-derived colony of undifferentiated human mesenchymal stem cells reveals mRNAs of multiple cell lineages. Stem cells 19, 408-418 (2001)
91. W. Wagner, F. Wein, A. Seckinger, M. Frankhauser, U. Wirkner, U. Krause, J. Blake, C. Schwager, V. Eckstein, W. Ansorge, A.D. Ho, Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp. Hem. 33, 1402-1416 (2005)
92. W. Wagner, R.E. Feldmann Jr, A. Seckinger, M.H. Maurer, F. Wein, J. Blake, U. Krause, A. Kalenka, H.F. Burgers, R. Saffrich, P. Wuchter, W. Kuschinsky, A.D. Ho, The heterogeneity of human mesenchymal stem cell preparations-evidence from simultaneous analysis of proteomes and transcriptomes. Exp. Hem. 34, 536-548 (2006)
93. P. Dentelli, C. Barale, G. Togliatto, A. Trombetta, C. Olgasi, M. Gili, C. Riganti, M. Toppino, M.F. Brizzi, A diabetic milieu promotes OCT4 and NANOG production in human visceral-derived adipose stem cells. Diabetologia 56, 173-184 (2013)
94. J.A. Thomson, J. Itskovitz-Eldor, S.S. Shapiro, M.A. Waknitz, J.J. Swiergiel, V.S. Marshall, J.M. Jones, Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998)
95. H.J. Rippon, A.E. Bishop, Embryonic stem cells. Cell Prolif. 37, 23-34 (2004)
96. B. Blum, N. Benvenisty, The tumorigenicity of human embryonic stem cells. Adv. Cancer Res. 100, 133-158 (2008)
97. K. Takahashi, S. Yamanaka, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006)
98. N.J. Leeper, A.L. Hunter, J.P. Cooke, Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells. Circulation 122, 517-526 (2010)
99. K.S. Volz, E. Miljan, A. Khoo, J.P. Cooke, Development of pluripotent stem cells for vascular therapy. Vasc. Pharmacol. 56, 288-296 (2012)
100. K. Okita, M. Nakagawa, H. Hyenjong, T. Ichisaka, S. Yamanaka, Generation of mouse induced pluripotent stem cells without viral vectors. Science 322, 949-953 (2008)
101. M. Bellin, M.C. Marchetto, F.H. Gage, C.L. Mummery, Induced pluripotent stem cells: the new patient? Nat. Rev. Mol. Cell Biol. 13, 713-726 (2012)
102. J.M. Hill, G. Zalos, J.P. Halcox, W.H. Schenke, M.A. Waclawiw, A.A. Quyyumi, T. Finkel, Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Eng. J. Med. 348, 593-600 (2003)
103. G.P. Fadini, C. Agostini, A. Avogaro, Endothelial progenitor cells and vascular biology in diabetes mellitus: current knowledge and future perspectives. Curr. Diabetes Rev. 1, 41-58 (2005)
104. G. Togliatto, A. Trombetta, P. Dentelli, A. Baragli, A. Rosso, R. Granata, D. Ghigo, L. Pegoraro, E. Ghigo, M.F. Brizzi, Unacylated ghrelin rescues endothelial progenitor cell function in individuals with type 2 diabetes. Diabetes 59, 1016-1025 (2010)
105. M.S. Ruiter, J.M. van Golde, N.C. Schaper, C.D. Stehouwer, M.S. Huijberts, Diabetes impairs arteriogenesis in the peripheral circulation: review of molecular mechanisms. Clin. Sci. (Lond.) 119, 225-238 (2010)
106. O.M. Tepper, R.D. Galiano, J.M. Capla, C. Kalka, P.J. Gagne, G.R. Jacobowitz, J.P. Levine, G.C. Gurtner, Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106, 2781-2786 (2002)
107. C.J. Loomans, E.J. de Koning, F.J. Staal, M.B. Rookmaaker, C. Verseyden, H.C. de Boer, M.C. Verhaar, B. Braam, T.J. Rabelink, A.J. van Zonneveld, Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53, 195-199 (2004)
108. A. Trombetta, G. Togliatto, A. Rosso, P. Dentelli, C. Olgasi, P. Cotogni, M. F. Brizzi, Increase of palmitic acid concentration impairs endothelial progenitor cell and bone marrow-derived progenitor cell bioavailability: role of the signal transducer and activator of transcription 5/peroxisome proliferator-activated receptor gamma transcriptional complex. diabetes (2012)
109. A. Rosso, A. Balsamo, R. Gambino, P. Dentelli, R. Falcioni, M. Cassader, L. Pegoraro, G. Pagano, M.F. Brizzi, p53 Mediates the accelerated onset of senescence of endothelial progenitor cells in diabetes. J. Biol. Chem. 281, 4339-4347 (2006)
110. J.W. Baynes, Role of oxidative stress in development of complications in diabetes. Diabetes 40, 405-412 (1991)
111. G.C. Schatteman, H.D. Hanlon, C. Jiao, S.G. Dodds, B.A. Christy, Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J. Clin. Invest. 106, 571-578 (2000)
112. M. Albiero, A. Avogaro, G. P. Fadini, Restoring stem cell mobilization to promote vascular repair in diabetes. Vasc. pharmacol. (2013)
113. G. P. Fadini, A. Avogaro, Diabetes impairs mobilization of stem cells for the treatment of cardiovascular disease: A meta-regression analysis. Int. J. Cardiol. (2012)
114. J. Yan, G. Tie, S. Wang, K. E. Messina, S. DiDato, S. Guo, L. M. Messina, Type 2 diabetes restricts multipotency of mesenchymal stem cells and impairs their capacity to augment postischemic neovascularization in db/db mice. J. Am. Heart Assoc. 1(6), e002238 (2012)
115. C. Berry, J.C. Tardif, M.G. Bourassa, Coronary heart disease in patients with diabetes: part I: recent advances in prevention and noninvasive management. J. Am. Coll. Cardiol. 49, 631-642 (2007)
116. R.M. Jacoby, R.W. Nesto, Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis. J. Am. Coll. Cardiol. 20, 736-744 (1992)
117. S.L. Woodfield, C.F. Lundergan, J.S. Reiner, S.W. Greenhouse, M.A. Thompson, S.C. Rohrbeck, Y. Deychak, M.L. Simoons, R.M. Califf, E.J. Topol, A.M. Ross, Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. J. Am. Coll. Cardiol. 28, 1661-1669 (1996)
118. S. Yusuf, G. Dagenais, J. Pogue, J. Bosch, P. Sleight, Vitamin E supplementation and cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators. N. Eng. J. Med. 342, 154-160 (2000)
119. M. Luo, X. Guan, E.D. Luczak, D. Lang, W. Kutschke, Z. Gao, J. Yang, P. Glynn, S. Sossalla, P.D. Swaminathan, R.M. Weiss, B. Yang, A.G. Rokita, L.S. Maier, I.R. Efimov, T.J. Hund, M.E. Anderson, Diabetes increases mortality after myocardial infarction by oxidizing CaMKII. J. Clin. Invest. 123, 1262-1274 (2013)
120. P. Valensi, E. Cosson, It is not yet the time to stop screening diabetic patients for silent myocardial ischaemia. Diabetes Metab. 36, 91-96 (2010)
121. C. Gazzaruso, A. Coppola, T. Montalcini, C. Valenti, A. Garzaniti, G. Pelissero, F. Salvucci, P. Gallotti, A. Pujia, C. Falcone, S.B. Solerte, A. Giustina, Erectile dysfunction can improve the effectiveness of the current guidelines for the screening for asymptomatic coronary artery disease in diabetes. Endocrine 40, 273-279 (2011)
122. A. Prasad, G.W. Stone, T.D. Stuckey, C.O. Costantini, P.J. Zimetbaum, M. McLaughlin, R. Mehran, E. Garcia, J.E. Tcheng, D.A. Cox, C.L. Grines, A.J. Lansky, B.J. Gersh, Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction. J. Am. Coll. Cardiol. 45, 508-514 (2005)
123. K.H. Mak, E.J. Topol, Emerging concepts in the management of acute myocardial infarction in patients with diabetes mellitus. J. Am. Coll. Cardiol. 35, 563-568 (2000)
124. X. Yin, Y. Zheng, X. Zhai, X. Zhao, L. Cai, Diabetic inhibition of preconditioning- and postconditioning-mediated myocardial protection against ischemia/reperfusion injury. Exp. Diabetes Res. 2012, 198048 (2012)
125. B.E. Strauer, R. Kornowski, Stem cell therapy in perspective. Circulation 107, 929-934 (2003)
126. M. T. Abdel Aziz, M. F. El-Asmar, M. Haidara, H. M. Atta, N. K. Roshdy, L. A. Rashed, D. Sabry, M. A. Youssef, A. T. Abdel Aziz, M. Moustafa, Effect of bone marrow-derived mesenchymal stem cells on cardiovascular complications in diabetic rats. Med Sci Monit. 14, BR249-255 (2008)
127. J.H. Li, N. Zhang, J.A. Wang, Improved anti-apoptotic and anti-remodeling potency of bone marrow mesenchymal stem cells by anoxic pre-conditioning in diabetic cardiomyopathy. J. Endocrinol. Invest. 31, 103-110 (2008)
128. J. A. Govaert, R. J. Swijnenburg, S. Schrepfer, X. Xie, K. E. van der Bogt, G. Hoyt, W. Stein, K. J. Ransohoff, R. C. Robbins, J. C. Wu, Poor functional recovery after transplantation of diabetic bone marrow stem cells in ischemic myocardium. J Heart Lung Transplant. 28, 1158-1165 e1151 (2009)
129. T. Kinnaird, E. Stabile, M.S. Burnett, C.W. Lee, S. Barr, S. Fuchs, S.E. Epstein, Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ. Res. 94, 678-685 (2004)
130. M. Gnecchi, H. He, O.D. Liang, L.G. Melo, F. Morello, H. Mu, N. Noiseux, L. Zhang, R.E. Pratt, J.S. Ingwall, V.J. Dzau, Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med. 11, 367-368 (2005)
131. M. Gnecchi, H. He, N. Noiseux, O.D. Liang, L. Zhang, F. Morello, H. Mu, L.G. Melo, R.E. Pratt, J.S. Ingwall, V.J. Dzau, Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 20, 661-669 (2006)
132. R. Mingliang, Z. Bo, W. Zhengguo, Stem cells for cardiac repair: status, mechanisms, and new strategies. Stem cells int. 2011, 310928 (2011)
133. Y. Bai, T. Sun, P. Ye, Age, gender and diabetic status are associated with effects of bone marrow cell therapy on recovery of left ventricular function after acute myocardial infarction: a systematic review and meta-analysis. Ageing Res. Rev. 9, 418-423 (2010)
134. F.M. Rauscher, P.J. Goldschmidt-Clermont, B.H. Davis, T. Wang, D. Gregg, P. Ramaswami, A.M. Pippen, B.H. Annex, C. Dong, D.A. Taylor, Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108, 457-463 (2003)
135. L. Menegazzo, M. Albiero, A. Avogaro, G.P. Fadini, Endothelial progenitor cells in diabetes mellitus. BioFactors 38, 194-202 (2012)
136. W. Ruan, C.Z. Pan, G.Q. Huang, Y.L. Li, J.B. Ge, X.H. Shu, Assessment of left ventricular segmental function after autologous bone marrow stem cells transplantation in patients with acute myocardial infarction by tissue tracking and strain imaging. Chin. Med. J. (Engl) 118, 1175-1181 (2005)
137. R.S. Karpov, S.V. Popov, V.A. Markov, T.E. Suslova, V.V. Ryabov, Y.S. Poponina, A.L. Krylov, S.V. Sazonova, Autologous mononuclear bone marrow cells during reparative regeneratrion after acute myocardial infarction. Bull. Exp. Biol. Med. 140, 640-643 (2005)
138. S. Janssens, C. Dubois, J. Bogaert, K. Theunissen, C. Deroose, W. Desmet, M. Kalantzi, L. Herbots, P. Sinnaeve, J. Dens, J. Maertens, F. Rademakers, S. Dymarkowski, O. Gheysens, J. Van Cleemput, G. Bormans, J. Nuyts, A. Belmans, L. Mortelmans, M. Boogaerts, F. Van de Werf, Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367, 113-121 (2006)
139. R.C. Huang, K. Yao, Y.Z. Zou, L. Ge, J.Y. Qian, J. Yang, S. Yang, Y.H.
140. H.J. Kang, H.Y. Lee, S.H. Na, S.A. Chang, K.W. Park, H.K. Kim, S.Y. Kim, H.J. Chang, W. Lee, W.J. Kang, B.K. Koo, Y.J. Kim, D.S. Lee, D.W. Sohn, K.S. Han, B.H. Oh, Y.B. Park, H.S. Kim, Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation 114, I145-I151 (2006)
141. J. Ge, Y. Li, J. Qian, J. Shi, Q. Wang, Y. Niu, B. Fan, X. Liu, S. Zhang, A. Sun, Y. Zou, Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI). Heart 92, 1764-1767 (2006)
142. F. Cao, D. Sun, C. Li, K. Narsinh, L. Zhao, X. Li, X. Feng, J. Zhang, Y. Duan, J. Wang, D. Liu, H. Wang, Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up. Eur. Heart J. 30, 1986-1994 (2009)
143. S. Grajek, M. Popiel, L. Gil, P. Breborowicz, M. Lesiak, R. Czepczynski, K. Sawinski, E. Straburzynska-Migaj, A. Araszkiewicz, A. Czyz, M. Kozlowska-Skrzypczak, M. Komarnicki, Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: Impact of bone marrow stem cell intracoronary infusion on improvement of microcirculation. Eur.Heart J. 131, 691-702 (2010)
144. J. Chen, J. Chen, S. Chen, C. Zhang, L. Zhang, X. Xiao, A. Das, Y. Zhao, B. Yuan, M. Morris, B. Zhao, Y. Chen, Transfusion of CXCR4-primed endothelial progenitor cells reduces cerebral ischemic damage and promotes repair in db/db diabetic mice. PLoS ONE 7, e50105 (2012)
145. J.M. Hare, J.H. Traverse, T.D. Henry, N. Dib, R.K. Strumpf, S.P. Schulman, G. Gerstenblith, A.N. DeMaria, A.E. Denktas, R.S. Gammon, J.B. Hermiller Jr, M.A. Reisman, G.L. Schaer, W. Sherman, A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 54, 2277-2286 (2009)
146. M. Shanmugasundaram, V.K. Ram, U.C. Luft, M. Szerlip, J.S. Alpert, Peripheral arterial disease-what do we need to know? Clin. Cardiol. 34, 478-482 (2011)
147. American Diabetes Association, Peripheral arterial disease in people with diabetes. Diabetes Care 26, 3333-3341 (2003)
148. E.B. Jude, I. Eleftheriadou, N. Tentolouris, Peripheral arterial disease in diabetes-a review. Diabet. Med. 27, 4-14 (2010)
149. S. Gandhi, I. Weinberg, R. Margey, M.R. Jaff, Comprehensive medical management of peripheral arterial disease. Prog. Cardiovasc. Dis. 54, 2-13 (2011)
150. R. Baffour, J. Berman, J.L. Garb, S.W. Rhee, J. Kaufman, P. Friedmann, Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J. Vasc. Surg. 16, 181-191 (1992)
151. P. Carmeliet, L. Moons, A. Luttun, V. Vincenti, V. Compernolle, M. De Mol, Y. Wu, F. Bono, L. Devy, H. Beck, D. Scholz, T. Acker, T. DiPalma, M. Dewerchin, A. Noel, I. Stalmans, A. Barra, S. Blacher, T. VandenDriessche, A. Ponten, U. Eriksson, K.H. Plate, J.M. Foidart, W. Schaper, D.S. Charnock-Jones, D.J. Hicklin, J.M. Herbert, D. Collen, M.G. Persico, Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 7, 575-583 (2001)
152. C. Borselli, H. Storrie, F. Benesch-Lee, D. Shvartsman, C. Cezar, J.W. Lichtman, H.H. Vandenburgh, D.J. Mooney, Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors. Proc. Natl. Acad. Sci. U S A107, 3287-3292 (2010)
153. S. Yla-Herttuala, K. Alitalo, Gene transfer as a tool to induce therapeutic vascular growth. Nat. Med. 9, 694-701 (2003)
154. C.A. Mack, C.J. Magovern, K.T. Budenbender, S.R. Patel, E.A. Schwarz, P. Zanzonico, B. Ferris, T. Sanborn, P. Isom, B. Ferris, T. Sanborn, O.W. Isom, R.G. Crystal, T.K. Rosengart, Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion. J. Vasc. Surg. 27, 699-709 (1998)
155. N. Ohara, H. Koyama, T. Miyata, H. Hamada, S.I. Miyatake, M. Akimoto, H. Shigematsu, Adenovirus-mediated ex vivo gene transfer of basic fibroblast growth factor promotes collateral development in a rabbit model of hind limb ischemia. Gene Ther. 8, 837-845 (2001)
156. D.S. Chang, H. Su, G.L. Tang, L.S. Brevetti, R. Sarkar, R. Wang, Y.W. Kan, L.M. Messina, Adeno-associated viral vector-mediated gene transfer of VEGF normalizes skeletal muscle oxygen tension and induces arteriogenesis in ischemic rat hindlimb. Mol. Ther. 7, 44-51 (2003)
157. F.D. Olea, G. Vera Janavel, L. Cuniberti, G. Yannarelli, P. Cabeza Meckert, J. Cors, L. Valdivieso, G. Lev, O. Mendiz, A. Bercovich, M. Criscuolo, C. Melo, R. Laguens, A. Crottogini, Repeated, but not single, VEGF gene transfer affords protection against ischemic muscle lesions in rabbits with hindlimb ischemia. Gene Ther. 16, 716-723 (2009)
158. E.V. De Paula, M.C. Flores-Nascimento, V.R. Arruda, R.A. Garcia, C.D. Ramos, A.T. Guillaumon, J.M. Annichino-Bizzacchi, Dual gene transfer of fibroblast growth factor-2 and platelet derived growth factor-BB using plasmid deoxyribonucleic acid promotes effective angiogenesis and arteriogenesis in a rodent model of hindlimb ischemia. Transl. Res.: J. Lab. Clin. Med. 153, 232-239 (2009)
159. E.B. Sneider, P.T. Nowicki, L.M. Messina, Regenerative medicine in the treatment of peripheral arterial disease. J. Cell. Biochem. 108, 753-761 (2009)
160. S. Rajagopalan, E.R. Mohler 3rd, R.J. Lederman, F.O. Mendelsohn, J.F. Saucedo, C.K. Goldman, J. Blebea, J. Macko, P.D. Kessler, H.S. Rasmussen, B.H. Annex, Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 108, 1933-1938 (2003)
161. R.J. Powell, M. Simons, F.O. Mendelsohn, G. Daniel, T.D. Henry, M. Koga, R. Morishita, B.H. Annex, Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia. Circulation 118, 58-65 (2008)
162. S. Nikol, I. Baumgartner, E. Van Belle, C. Diehm, A. Visona, M.C. Capogrossi, N. Ferreira-Maldent, A. Gallino, M.G. Wyatt, L.D. Wijesinghe, M. Fusari, D. Stephan, J. Emmerich, G. Pompilio, F. Vermassen, E. Pham, V. Grek, M. Coleman, F. Meyer, T. Investigators, Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. Mol. Ther. 16, 972-978 (2008)
163. G. Cobellis, A. Silvestroni, S. Lillo, G. Sica, C. Botti, C. Maione, V. Schiavone, S. Rocco, G. Brando, V. Sica, Long-term effects of repeated autologous transplantation of bone marrow cells in patients affected by peripheral arterial disease. Bone Marrow Transplant. 42, 667-672 (2008)
164. A. Ranghino, V. Cantaluppi, C. Grange, L. Vitillo, F. Fop, L. Biancone, M.C. Deregibus, C. Tetta, G.P. Segoloni, G. Camussi, Endothelial progenitor cell-derived microvesicles improve neovascularization in a murine model of hindlimb ischemia. Int. J. Immunopathol. Pharmacol. 25, 75-85 (2012)
165. R.B. Van Tongeren, J.F. Hamming, W.E. Fibbe, V. Van Weel, S.J. Frerichs, A.M. Stiggelbout, J.H. Van Bockel, J.H. Lindeman, Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia. J. Cardiovasc. Surg. (Torino) 49, 51-58 (2008)
166. K. Lenk, V. Adams, P. Lurz, S. Erbs, A. Linke, S. Gielen, A. Schmidt, D. Scheinert, G. Biamino, F. Emmrich, G. Schuler, R. Hambrecht, Therapeutical potential of blood-derived progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischaemia. Eur. Heart J. 26, 1903-1909 (2005)
167. R.W. Sprengers, F.L. Moll, M. Teraa, M.C. Verhaar, J.S. Group, Rationale and design of the JUVENTAS trial for repeated intra-arterial infusion of autologous bone marrow-derived mononuclear cells in patients with critical limb ischemia. J. Vasc. Surg. 51, 1564-1568 (2010)
168. W. Fan, D. Sun, J. Liu, D. Liang, Y. Wang, K.H. Narsinh, Y. Li, X. Qin, J. Liang, J. Tian, F. Cao, Adipose stromal cells amplify angiogenic signaling via the VEGF/mTOR/Akt pathway in a murine hindlimb ischemia model: a 3D multimodality imaging study. PLoS ONE 7, e45621 (2012)
169. L.R. Wechsler, Intravenous thrombolytic therapy for acute ischemic stroke. N. Eng. J. Med. 364, 2138-2146 (2011)
170. L.H. Schwamm, M.J. Reeves, W. Pan, E.E. Smith, M.R. Frankel, D. Olson, X. Zhao, E. Peterson, G.C. Fonarow, Race/ethnicity, quality of care, and outcomes in ischemic stroke. Circulation 121, 1492-1501 (2010)
171. L.B. Goldstein, C.D. Bushnell, R.J. Adams, L.J. Appel, L.T. Braun, S. Chaturvedi, M.A. Creager, A. Culebras, R.H. Eckel, R.G. Hart, J.A. Hinchey, V.J. Howard, E.C. Jauch, S.R. Levine, J.F. Meschia, W.S. Moore, J.V. Nixon, T.A. Pearson, American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Epidemiology and Prevention; Council for High Blood Pressure Research,; Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research.: guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42, 517-584 (2011)
172. J.P. Broderick, P.M. Meyers, Acute stroke therapy at the crossroads. JAMA 306, 2026-2028 (2011)
173. H.P. Adams Jr, G. del Zoppo, M.J. Alberts, D.L. Bhatt, L. Brass, A. Furlan, R.L. Grubb, R.T. Higashida, E.C. Jauch, C. Kidwell, P.D. Lyden, L.B. Morgenstern, A.I. Qureshi, R.H. Rosenwasser, P.A. Scott, E.F. Wijdicks, American Heart Association; American Stroke Association Stroke Council; Clinical Cardiology Council; Cardiovascular Radiology and Intervention Council; Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 38, 1655-1711 (2007)
174. N.K. Mishra, S.M. Davis, M. Kaste, K.R. Lees, V. Collaboration, Comparison of outcomes following thrombolytic therapy among patients with prior stroke and diabetes in the Virtual International Stroke Trials Archive (VISTA). Diabetes Care 33, 2531-2537 (2010)
175. D.J. Maron, W.E. Boden, J.A. Spertus, P.M. Hartigan, G.B. Mancini, S.P. Sedlis, W.J. Kostuk, B.R. Chaitman, L.J. Shaw, D.S. Berman, M. Dada, K.K. Teo, W.S. Weintraub, R.A. O'Rourke, COURAGE Trial Research Group: impact of metabolic syndrome and diabetes on prognosis and outcomes with early percutaneous coronary intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial. J. Am. Coll. Cardiol. 58, 131-137 (2011)
176. C. Rosso, J.C. Corvol, C. Pires, S. Crozier, Y. Attal, S. Jacqueminet, S. Deltour, G. Multlu, A. Leger, I. Meresse, C. Payan, D. Dormont, Y. Samson, Intensive versus subcutaneous insulin in patients with hyperacute stroke: results from the randomized INSULINFARCT trial. Stroke 43, 2343-2349 (2012)
177. O.Y. Bang, J.S. Lee, P.H. Lee, G. Lee, Autologous mesenchymal stem cell transplantation in stroke patients. Ann. Neurol. 57, 874-882 (2005)
178. M. A. Friedrich, M. P. Martins, M. D. Araujo, C. Klamt, L. Vedolin, B. Garicochea, E. F. Raupp, J. S. Ammar, D. C. Machado, J. C. Costa, R. G. Nogueira, P. H. Rosado-de-Castro, R. Mendez-Otero, G. R. de Freitas, Intra-arterial infusion of autologous bone-marrow mononuclear cells in patients with moderate to severe middle-cerebral-artery acute ischemic stroke. Cell Transplant. (2011)
179. M. Chopp, Y. Li, Treatment of neural injury with marrow stromal cells. Lancet neurol. 1, 92-100 (2002)
180. A. Taguchi, T. Matsuyama, H. Moriwaki, T. Hayashi, K. Hayashida, K. Nagatsuka, K. Todo, K. Mori, D.M. Stern, T. Soma, H. Naritomi, Circulating CD34-positive cells provide an index of cerebrovascular function. Circulation 109, 2972-2975 (2004)
181. T. Sobrino, O. Hurtado, M.A. Moro, M. Rodriguez-Yanez, M. Castellanos, D. Brea, O. Moldes, M. Blanco, J.F. Arenillas, R. Leira, A. Davalos, I. Lizasoain, J. Castillo, The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome. Stroke 38, 2759-2764 (2007)
182. H.K. Yip, L.T. Chang, W.N. Chang, C.H. Lu, C.W. Liou, M.Y. Lan, J.S. Liu, A.A. Youssef, H.W. Chang, Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke. Stroke 39, 69-74 (2008)
183. F. Pescini, F. Cesari, B. Giusti, C. Sarti, E. Zicari, S. Bianchi, M.T. Dotti, A. Federico, M. Balestrino, A. Enrico, C. Gandolfo, A.M. Gori, R. Abbate, L. Pantoni, D. Inzitari, Bone marrow-derived progenitor cells in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke 41, 218-223 (2010)
184. J. Chen, X. Ye, T. Yan, C. Zhang, X.P. Yang, X. Cui, Y. Cui, A. Zacharek, C. Roberts, X. Liu, X. Dai, M. Lu, M. Chopp, Adverse effects of bone marrow stromal cell treatment of stroke in diabetic rats. Stroke 42, 3551-3558 (2011)
185. G.P. Fadini, M. Miorin, M. Facco, S. Bonamico, I. Baesso, F. Grego, M. Menegolo, S.V. de Kreutzenberg, A. Tiengo, C. Agostini, A. Avogaro, Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J. Am. Coll. Cardiol. 45, 1449-1457 (2005)
186. S.A. Sorrentino, F.H. Bahlmann, C. Besler, M. Muller, S. Schulz, N. Kirchhoff, C. Doerries, T. Horvath, A. Limbourg, F. Limbourg, D. Fliser, H. Haller, H. Drexler, U. Landmesser, Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Circulation 116, 163-173 (2007)
187. P. Dentelli, A. Trombetta, G. Togliatto, A. Zeoli, A. Rosso, B. Uberti, F. Orso, D. Taverna, L. Pegoraro, M.F. Brizzi, Formation of STAT5/PPARgamma transcriptional complex modulates angiogenic cell bioavailability in diabetes. Arterioscler. Thromb. Vasc. Biol. 29, 114-120 (2009)
188. G. Togliatto, A. Trombetta, P. Dentelli, A. Rosso, M.F. Brizzi, MIR221/MIR222-driven post-transcriptional regulation of P27KIP1 and P57KIP2 is crucial for high-glucose- and AGE-mediated vascular cell damage. Diabetologia 54, 1930-1940 (2011)
189. K. Sasaki, C. Heeschen, A. Aicher, T. Ziebart, J. Honold, C. Urbich, L. Rossig, U. Koehl, M. Koyanagi, A. Mohamed, R. P. Brandes, H. Martin, A. M. Zeiher, S. Dimmeler, Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy. Proc. Natl. Acad. Sci. U S A. 103, 14537-14541 (2006)
190. D.H. Walter, U. Rochwalsky, J. Reinhold, F. Seeger, A. Aicher, C. Urbich, I. Spyridopoulos, J. Chun, V. Brinkmann, P. Keul, B. Levkau, A.M. Zeiher, S. Dimmeler, J. Haendeler, Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor. Arterioscler. Thromb. Vasc. Biol. 27, 275-282 (2007)
191. S. Murasawa, J. Llevadot, M. Silver, J.M. Isner, D.W. Losordo, T. Asahara, Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells. Circulation 106, 1133-1139 (2002)
192. M.I. Niagara, H. Haider, S. Jiang, M. Ashraf, Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ. Res. 100, 545-555 (2007)
193. F.H. Seeger, A.M. Zeiher, S. Dimmeler, Cell-enhancement strategies for the treatment of ischemic heart disease. Nat. Clin. Pract. Cardiovasc. Med. 4, S110-S113 (2007)
194. K. Larsen, C. Cheng, D. Tempel, S. Parker, S. Yazdani, W.K. den Dekker, J.H. Houtgraaf, R. de Jong, S. Swager-ten Hoor, E. Ligtenberg, S.R. Hanson, S. Rowland, S. Rowland, S. Rowland, F. Kolodgie, P.W. Serruys, R. Virmani, H.J. Duckers, Capture of circulatory endothelial progenitor cells and accelerated re-endothelialization of a bio-engineered stent in human ex vivo shunt and rabbit denudation model. Eur. Heart J. 33, 120-128 (2012)
195. E. Fuchs, T. Tumbar, G. Guasch, Socializing with the neighbors: stem cells and their niche. Cell 116, 769-778 (2004)
196. M.F. Brizzi, G. Tarone, P. Defilippi, Extracellular matrix, integrins, and growth factors as tailors of the stem cell niche. Curr. Opin. Cell Biol. 24, 645-651 (2012)
197. K.H. Nakayama, C.A. Batchelder, C.I. Lee, A.F. Tarantal, Decellularized rhesus monkey kidney as a three-dimensional scaffold for renal tissue engineering. Tissue Eng. Part A 16, 2207-2216 (2010)
198. H. Sekiguchi, M. Ii, D.W. Losordo, The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemia. J. Cell. Physiol. 219, 235-242 (2009)
199. D.W. Losordo, R.A. Schatz, C.J. White, J.E. Udelson, V. Veereshwarayya, M. Durgin, K.K. Poh, R. Weinstein, M. Kearney, M. Chaudhry, A. Burg, L. Eaton, L. Heyd, T. Thorne, L. Shturman, P. Hoffmeister, K. Story, V. Zak, D. Dowling, J.H. Traverse, R.E. Olson, J. Flanagan, D. Sodano, T. Murayama, A. Kawamoto, K.F. Kusano, J. Wollins, F. Welt, P. Shah, P. Soukas, T. Asahara, T.D. Henry, Intramyocardial transplantation of autologous CD34 + stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation 115, 3165-3172 (2007)
200. D. W. Losordo, T. D. Henry, C. Davidson, J. Sup Lee, M. A. Costa, T. Bass, F. Mendelsohn, F. D. Fortuin, C. J. Pepine, J. H. Traverse, D. Amrani, B. M. Ewenstein, N. Riedel, K. Story, K. Barker, T. J. Povsic, R. A. Harrington, R. A. Schatz, A. C. Investigators, Intramyocardial, autologous CD34 + cell therapy for refractory angina. Circ. res. 109, 428-436 (2011)
201. F.H. Seeger, T. Rasper, A. Fischer, M. Muhly-Reinholz, E. Hergenreider, D.M. Leistner, K. Sommer, Y. Manavski, R. Henschler, E. Chavakis, B. Assmus, A.M. Zeiher, S. Dimmeler, Heparin disrupts the CXCR4/SDF-1 axis and impairs the functional capacity of bone marrow-derived mononuclear cells used for cardiovascular repair. Circ. Res. 111, 854-862 (2012)
202. L.G. Melo, A.S. Pachori, D. Kong, M. Gnecchi, K. Wang, R.E. Pratt, V.J. Dzau, Molecular and cell-based therapies for protection, rescue, and repair of ischemic myocardium: reasons for cautious optimism. Circ. 109, 2386-2393 (2004)
203. M. Takahashi, T.S. Li, R. Suzuki, T. Kobayashi, H. Ito, Y. Ikeda, M. Matsuzaki, K. Hamano, Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury. Am. J. Physiol. Heart Circ. Physiol. 291, 886-893 (2006)
204. R. Bassi, A. Trevisani, S. Tezza, M. Ben Nasr, F. Gatti, A. Vergani, A. Farina, P. Fiorina, Regenerative therapies for diabetic microangiopathy. Exp. Diabetes Res. 2012, 916560 (2012)
205. C.E. Glass, P.K. Singal, D.K. Singla, Stem cells in the diabetic infarcted heart. Heart Fail. Rev. 15, 581-588 (2010)
206. A.R. Williams, J.M. Hare, Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ. Res. 109, 923-940 (2011)
207. S.L. Chen, W.W. Fang, F. Ye, Y.H. Liu, J. Qian, Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction. Am. J. Cardiol. 94, 92-95 (2004)